Walleye Trading’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-27,300
Closed -$494K – 4252
2026
Q1
$494K Sell
27,300
-8,900
-25% -$170K ﹤0.01% 2599
2025
Q4
$787K Buy
36,200
+28,500
+370% +$816K ﹤0.01% 2525
2025
Q3
$251K Buy
7,700
+5,300
+221% +$196K ﹤0.01% 3207
2025
Q2
$85.2K Sell
2,400
-6,000
-71% -$194K ﹤0.01% 3658
2025
Q1
$285K Buy
8,400
+100
+1% +$3.59K ﹤0.01% 2873
2024
Q4
$270K Buy
+8,300
New +$344K ﹤0.01% 3061
2024
Q1
– Sell
-9,500
Closed -$572K – 5075
2023
Q4
$572K Buy
9,500
+5,400
+132% +$342K ﹤0.01% 2963
2023
Q3
$275K Buy
+4,100
New +$285K ﹤0.01% 3412
2023
Q2
– Sell
-900
Closed -$43.4K – 4944
2023
Q1
$43.4K Buy
+900
New +$44K ﹤0.01% 4109
2022
Q4
– Sell
-5,500
Closed -$224K – 5204
2022
Q3
$224K Buy
+5,500
New +$258K ﹤0.01% 3580

Other funds holding LEGN

Walleye Trading's LEGN Position: Q2 2026 in Review

Walleye Trading sold out of Legend Biotech (LEGN) in Q2 2026, closing a stake of 12,744 shares — an estimated $231K sold.

Walleye Trading first reported a position in LEGN in Q3 2023 and held it in 6 quarters. The position peaked at $231K in Q1 2026. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Walleye Trading reported no remaining Legend Biotech position as of Q2 2026 after selling out during the quarter.
  • Walleye Trading sold 12,744 Legend Biotech shares in Q2 2026, an estimated $231K.
  • Walleye Trading first reported a position in Legend Biotech in Q3 2023 and held it in 6 quarters.
  • Walleye Trading's Legend Biotech position peaked at $231K in Q1 2026.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.